Effect of anti-transforming growth factor-β antibodies in cyclosporine-induced renal dysfunction

Muhammad Islam, James F. Burke, Tracy A. McGowan, Yanqing Zhu, Stephen R. Dunn, Peter McCue, John Kanalas, Kumar Sharma

Research output: Contribution to journalArticle

97 Scopus citations

Abstract

Background. Several experimental and clinical studies have implicated a role for transforming growth factor-β (TGF-β) in mediating the nephrotoxic effects of cyclosporine (CsA). To test this hypothesis, we administered neutralizing anti-TGF-β antibodies (α-TGF-β) in a well-described rat model of chronic CsA nephrotoxicity. Methods. We studied three groups (N = 9 per group) of adult, male Sprague-Dawley rats that received a low-salt diet (0.05% sodium). Normal controls were given vehicle subcutaneously and an alternate-day intraperitoneal injection of 3 mg of nonspecific mouse IgG (MIgG) for 28 days. The CsA group received 15 mg/kg/day of CsA subcutaneously and 3 mg of MIgG intraperitoneally on alternate days for 28 days. The CsA/α-TGF-β group received CsA and alternate-day α-TGF-β (3 mg) for 28 days. At the end of 28 days, creatinine clearance was measured by 24-hour urine collection. Histologic assessment was performed for tubulointerstitial damage and arteriolar hyalinosis. Northern analysis was performed for α1(I) collagen and TGF-β1 gene expression, and quantitative reverse transcription-polymerase chain reaction was performed to measure levels of tissue inhibitor of metalloproteinase-1 (TIMP-1), TIMP-2, plasminogen activator inhibitor-1 (PAI-1), matrix metalloproteinase-2 (MMP-2), and MMP-9. Results. CsA-treated rats had significantly lower creatinine clearance as compared with normal controls (0.43 ± 0.07 vs. 0.67 ± 0.14 mL/min, P = 0.0002), increased interstitial damage and afferent arteriolar hyalinosis (P = 0.0001), and increased α1 (I) collagen (4-fold) and TGF-β1 (2.5-fold) mRNA expression. CsA-treated rats also had significantly increased TIMP-1 (7.4-fold, P < 0.001), MMP-2, and PAI-1 (all approximately 2-fold, P < 0.02) and decreased MMP-9 (85% reduction, P < 0.001) as compared with controls. Treatment with α-TGF-β in CsA-treated rats significantly prevented the reduction in creatinine clearance (0.58 ± 0.03 mL/min, P = 0.009 vs. CsA alone), the increase in afferent arteriolar hyalinosis (P < 0.05 vs. CsA alone), normalized α1(I) collagen mRNA levels, and attenuated CsA effects on TGF-β1, TIMP-1, and MMP-9. Conclusions. In this rat model of CsA-induced nephrotoxicity, renal insufficiency and characteristic histologic changes are associated with altered expression of matrix and matrix-regulating molecules. Based on our results with α-TGF-β antibodies, many but not all of these nephrotoxic effects of CsA are mediated by TGF-β.

Original languageEnglish (US)
Pages (from-to)498-506
Number of pages9
JournalKidney international
Volume59
Issue number2
DOIs
StatePublished - Jan 1 2001
Externally publishedYes

    Fingerprint

Keywords

  • Immunosuppression
  • Kidney failure
  • Matrix metalloproteinase
  • Nephrotoxicity
  • TIMP-1
  • Type I collagen

ASJC Scopus subject areas

  • Nephrology

Cite this